Home › Gilead Has Bottomed - The Question Is How Much Upside Ahead?
 

Keywords :   


Gilead Has Bottomed - The Question Is How Much Upside Ahead?

2016-02-16 05:34:09| Biotech - Topix.net

It has been a frightful six months for biotech investors as the main biotech indices have plunged some 40% from their peaks in July. However, it does appear the some of the big biotech names are in a bottoming phase which is needed before the sector can rally.

Tags: much question ahead upside

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »